Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Int J Tuberc Lung Dis. 2011 Aug;15(8):1111-6. doi: 10.5588/ijtld.10.0491.
The impact on patient mortality of combined pulmonary fibrosis and emphysema (CPFE) compared with emphysema alone has never been investigated.
To elucidate whether CPFE has an impact on overall mortality over that of emphysema alone.
We screened patients who underwent chest computed tomography (CT) scans during the period from 1 January 2001 to 31 December 2005 in a tertiary referral hospital. Patients who had both emphysema and pulmonary fibrosis, thus meeting the inclusion criteria, were defined as CPFE. Controls with emphysema alone who were matched for age, sex and the date of CT scan were randomly selected. Cox proportional regression analysis was performed to verify whether CPFE is associated with increased overall mortality.
We found 135 CPFE cases. In the multivariable Cox regression stratified by the presence of comorbid malignancy, CPFE had five times higher mortality risk (adjusted HR 5.10, 95%CI 1.75-14.9) in non-malignant cases, and showed a statistically insignificant trend for higher mortality risk (adjusted HR 1.70, 95%CI 0.94-2.51) in the malignant cases after adjusting for forced vital capacity, height and hypertension.
CPFE is not rare and CPFE patients had a higher overall mortality risk than emphysema-only patients.
合并性肺纤维化和肺气肿(CPFE)对患者死亡率的影响与单纯肺气肿相比从未被研究过。
阐明 CPFE 是否对总体死亡率有影响,超过单纯肺气肿的影响。
我们筛选了 2001 年 1 月 1 日至 2005 年 12 月 31 日期间在一家三级转诊医院接受胸部计算机断层扫描(CT)的患者。符合纳入标准的既有肺气肿又有肺纤维化的患者被定义为 CPFE。我们随机选择了年龄、性别和 CT 扫描日期匹配的单纯肺气肿患者作为对照。采用 Cox 比例风险回归分析来验证 CPFE 是否与总死亡率的增加相关。
我们发现了 135 例 CPFE 病例。在存在合并恶性肿瘤的多变量 Cox 回归分层中,非恶性病例中 CPFE 的死亡率风险高 5 倍(调整后的 HR 5.10,95%CI 1.75-14.9),在调整了用力肺活量、身高和高血压后,恶性病例中的死亡率风险有统计学上的升高趋势(调整后的 HR 1.70,95%CI 0.94-2.51)。
CPFE 并不罕见,CPFE 患者的总体死亡率风险高于单纯肺气肿患者。